Federica Gaiani

Parma, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study.

Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study.

Journal: American journal of therapeutics

Published: July 23, 2026

Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study.

Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study.

Journal: American journal of therapeutics

Published: July 23, 2026

Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study.

Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study.

Journal: Advances in therapy

Published: February 11, 2026

Fecal calprotectin and gut microbiome in a cohort without intestinal pathologies from northern Italy.

Fecal calprotectin and gut microbiome in a cohort without intestinal pathologies from northern Italy.

Journal: iScience

Published: January 30, 2026

Targeted nutritional prehabilitation for high-risk Crohn's disease patients undergoing elective gastrointestinal surgery: a case series.

Targeted nutritional prehabilitation for high-risk Crohn's disease patients undergoing elective gastrointestinal surgery: a case series.

Journal: Frontiers in nutrition

Published: October 24, 2025

Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.

Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.

Journal: Journal of clinical medicine

Published: August 27, 2025

Functional and morphological characterisation of human colonoid-derived monolayers under inflammatory conditions.

Functional and morphological characterisation of human colonoid-derived monolayers under inflammatory conditions.

Journal: International journal of pharmaceutics

Published: July 01, 2025

Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study.

Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study.

Journal: Intestinal research

Published: April 29, 2025

Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study.

Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study.

Journal: Journal of clinical medicine

Published: September 23, 2024

Gastrointestinal involvement in Henoch-Schönlein purpura.

Gastrointestinal involvement in Henoch-Schönlein purpura.

Journal: Journal of pediatric gastroenterology and nutrition

Published: April 05, 2024

Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study.

Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study.

Journal: Expert opinion on biological therapy

Published: January 22, 2024

Laparoscopy-assisted trans-hiatal endoscopic removal of an intragastric balloon after placement-related esophageal perforation.

Laparoscopy-assisted trans-hiatal endoscopic removal of an intragastric balloon after placement-related esophageal perforation.

Journal: Endoscopy

Published: November 07, 2023

Showing 1-12 of 78

Last Updated: 09/26/2026